DeHeng Advised Tongee on Raising

RMB 55 Millions in A New Round of Financing

2021-05-26

Hangzhou Tongee Medical Technology Co., Ltd., a company specialized in the R&D of therapeutic methods for metabolic diseases, recently announced the completion of its latest round of financing. The RMB 55 million investment was led by Baidu Venture, with Everest VC and Dingxin Capital as co-investors.

As the legal counsel of the company, the DeHeng team, with primary support from partner Zhang Lei and associates Fang Wen, Zhu Yun and Shang Shuili, participated in the drafting of documents, negotiation, closing and other matters of the deal. The DeHeng lawyers worked closely, professionally and efficiently to close the deal, winning the trust and recognition of the client and relevant parties. With a focus on emerging industries such as biomedicine, artificial intelligence, big data, TMT and top-tier manufacturing, DeHeng lawyers will leverage their rich project experience and industry resources accumulated over the years, and the ability to conduct swift, insightful research, to continuously provide high-quality legal services to our clients.